Developer docs
API playgroundTry for free, no card

Search company profiles

Tactile Medical

Full company profile

uuid0003yog

Namestring
Tactile Medical
Legal namestring
Tactile Systems Technology, Inc.
Company typeenum
Public
Founded yearint
1995
Descriptiontext

Tactile Medical (legal name Tactile Systems Technology, Inc.; NASDAQ: TCMD) is a Minneapolis-based medical technology company that develops, manufactures, and markets at-home pneumatic compression therapy systems and high-frequency chest wall oscillation (HFCWO) airway clearance devices. Its portfolio targets chronic conditions including lymphedema (primary, secondary, head and neck, and lipedema-related), chronic venous insufficiency (CVI), nonhealing venous leg ulcers, and chronic respiratory disorders such as cystic fibrosis, bronchiectasis, and neuromuscular disease. The company estimates the U.S. patient population at more than 20 million Americans affected by chronic swelling, including up to 40% of breast cancer survivors who develop lymphedema. Headcount is reported in the 251–500 range.

The core technology centers on proprietary multi-chambered intermittent pneumatic compression (IPC) garment systems — Flexitouch Plus (HCPCS E0652), Nimbl (HCPCS E0651), and the legacy Entre Plus — that deliver sequenced, wave-like pressure to mimic manual lymphatic drainage and stimulate lymphatic circulation. AffloVest, acquired from International Biophysics Corporation in September 2021, provides HFCWO airway clearance and received FDA 510(k) clearance for a next-generation connected version launching in June 2026. The ComfortEase garment line (zippers, numbered tabs, thinner fabric) was rolled out for lower extremity in June 2022 and upper extremity in June 2023. The Kylee mobile app (iOS/Android) pairs via Bluetooth with Flexitouch Plus and Nimbl to log treatments, track symptoms, and produce shareable clinician reports. The February 2026 acquisition of LymphaTech Inc. for $6.8M upfront adds 3D scanning technology for lymphedema assessment and monitoring. Clinical evidence cited includes 19+ clinical studies, 24+ peer-reviewed articles, and 1,800+ studied patients, with reported outcomes such as 88% (lower body) and 95% (upper body) limb volume reduction and 97% of head and neck patients reporting softer fibrotic tissue.

The business model is prescription-based, durable medical equipment (DME) reimbursed by Medicare, the Veterans Affairs Federal Supply Schedule (FSS 36F79718D0519), and commercial health plans covering more than 270 million lives. Tactile Medical monetizes primarily through one-time device sales (hardware), with accessory e-commerce (bags, batteries, garment pads) at shop.tactilemedical.com as a secondary, non-reimbursed stream; reimbursement and patient advocacy services are bundled into device revenue. Go-to-market combines enterprise-style direct field sales to clinicians (with digital ordering via Parachute Health), direct-to-patient fulfillment with in-home fitting and training, and a dedicated VA channel. FY2025 revenue of approximately $329.5M grew to Q1 2026 revenue of $75.3M (+23% YoY); FY2026 guidance was raised to $360–$368M with adjusted EBITDA of $49–$51M and gross margin reaching 76.5% in Q1 2026.

Short descriptiontext

Tactile Medical (NASDAQ: TCMD) develops and markets FDA-cleared at-home pneumatic compression devices (Flexitouch Plus, Nimbl, Entre Plus) and the AffloVest HFCWO airway clearance system, serving U.S. patients with lymphedema, lipedema, chronic venous insufficiency, and chronic respiratory conditions through prescription-based sales reimbursed by Medicare, the VA, and commercial health plans.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMinneapolis, United States
HQ citystring
Minneapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home pneumatic compression, lymphedema therapy devices, airway clearance vests, chronic venous insufficiency treatment, durable medical equipment
Industry5 codes
1Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
CodeHLAHAMAGPrimaryYes
2Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments)
CodeHLAHALAFPrimaryNo
3Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
CodeHLACAPABPrimaryNo
4Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
CodeHLAHAIAMPrimaryNo
5Durable Medical Equipment (DME) Sales & Rentals
CodeHSABAKAAPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
At-home pneumatic compression therapy devices
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pneumatic compression device sales
TypeHardware Sales
Description

Primary revenue stream from sale of Flexitouch Plus, Nimbl, Entre Plus, and AffloVest systems reimbursed by Medicare, Veterans Affairs, and commercial health plans representing more than 270 million lives. Devices are prescription-based and typically one-time purchases per patient.

tactilemedical.com
2Accessories sales via online storefront
TypeHardware Sales
Description

Direct e-commerce sales of accessories including travel bags, rechargeable batteries, power cords, and replacement garment pads through shop.tactilemedical.com. Items are not eligible for insurance reimbursement and require credit card payment.

tactilemedical.com
3Reimbursement and patient advocacy services
TypeProfessional Services
Description

Value-add service bundled with device sales: experienced reimbursement specialists streamline insurance navigation, prior authorizations, and appeals for patients, included as part of the total cost of the prescribed device.

tactilemedical.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Others
Pricing details2 tiers
1Insurance-reimbursed DME (Flexitouch Plus, Nimbl, Entre Plus, AffloVest)
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing not publicly disclosed. Reimbursed by Medicare, VA, and commercial health plans covering 270M+ lives based on medical necessity and documented failure of conservative therapy. Patient responsible for any applicable deductible/co-insurance.

tactilemedical.com
2Accessories e-commerce (bags, batteries, garment pads)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Pricing not publicly disclosed. Sold direct via shop.tactilemedical.com. Sales tax and FedEx Ground shipping/handling calculated at checkout. 60-day return window on unopened items in original packaging. Limited warranty on accessories.

tactilemedical.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Flexitouch
Description

Advanced intermittent pneumatic compression device system (including Flexitouch Plus) clinically proven for at-home self-management of lymphedema and nonhealing venous leg ulcers. Includes head/neck, upper body, and lower body garment variants with the ComfortEase garment line.

tactilemedical.com
+5 more records
Core offering1 text field

Tactile Medical develops, manufactures, and distributes at-home pneumatic compression therapy devices (Flexitouch Plus, Nimbl, Entre Plus) for the treatment of lymphedema, lipedema, and chronic venous insufficiency, plus the AffloVest high-frequency chest wall oscillation airway clearance system for chronic respiratory conditions. Devices are prescription-based durable medical equipment reimbursed by Medicare, Veterans Affairs, and commercial health plans, and are complemented by the Kylee Bluetooth-connected patient mobile app and accessories sold direct via the company's e-commerce storefront.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 88% of patients experience limb volume reduction with Flexitouch Plus lower body treatment
+5 more records
Product overview1 text field

Tactile Medical is a single-vendor medical technology company that develops and markets an integrated portfolio of at-home pneumatic compression therapy products for chronic disorders, principally lymphedema, lipedema, chronic venous insufficiency (CVI), and chronic respiratory conditions. The portfolio is built around the core Flexitouch Plus advanced pneumatic compression system (HCPCS E0652) and the Nimbl basic pneumatic compression system (HCPCS E0651), supported by the legacy Entre Plus system, the AffloVest high-frequency chest wall oscillation airway clearance system, the redesigned ComfortEase garment line for Flexitouch Plus, and the Kylee Bluetooth-connected companion mobile app for symptom tracking and treatment sharing. The acquisition of LymphaTech adds 3D scanning technology for lymphedema assessment and monitoring, extending the offering from discrete products toward an integrated digital lymphedema solutions platform with connected care and remote monitoring capabilities.

Product and service6 records
1Flexitouch Plus System
CategoryAdvanced pneumatic compression device
Description

Advanced intermittent pneumatic compression device (HCPCS E0652) that stimulates the lymphatic system for at-home self-management of lymphedema, chronic venous insufficiency (CVI), and nonhealing venous leg ulcers. Available with region-specific ComfortEase garments for head and neck, upper body, and lower body treatment.

2Nimbl System
CategoryBasic pneumatic compression device
Description

Compact, Bluetooth-connected pneumatic compression device (HCPCS E0651) with a small, light controller and eight sequential compression chambers for upper and lower body treatment of lymphedema and CVI. Pairs with the Kylee app for treatment tracking.

3AffloVest
CategoryAirway clearance therapy system
Description

High-frequency chest wall oscillation (HFCWO) airway clearance vest system for patients with chronic respiratory conditions including cystic fibrosis, bronchiectasis, COPD, and neuromuscular disorders. Gently loosens and mobilizes mucus for easier clearance at home or on the go.

4Entre Plus System
CategoryPneumatic compression device
Description

Intermittent pneumatic compression device (HCPCS E0651) for upper and lower body treatment of lymphedema. Supports approximately 60-minute treatment sessions in single-garment and bilateral configurations. Predecessor to the Nimbl product line.

5Kylee App
CategoryPatient-facing companion mobile application
Description

Free mobile app (iOS 18+ and Android 14+) for lymphedema and chronic swelling self-management. Connects via Bluetooth to Flexitouch Plus and Nimbl devices to track daily symptoms (swelling, pain, heaviness), log treatments, set reminders, monitor order status, and generate shareable activity reports of up to six months of history for healthcare teams.

6Tactile Medical Accessories
CategoryDevice accessories and consumables
Description

Direct-to-consumer e-commerce accessories (travel bags, rechargeable batteries, power cords, replacement garment pads) sold via shop.tactilemedical.com with FedEx Ground shipping, 60-day return window on unopened items, and credit card payment.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-18
Description

Tactile Medical acquired LymphaTech Inc. for $6.8 million in upfront cash (with potential milestone-based payments) to enhance its portfolio in lymphedema solutions and digital care. LymphaTech is a privately held medical technology company pioneering 3D scanning technology for assessing and monitoring lymphedema patients, supporting Tactile Medical's evolution from a product-based company to an integrated lymphedema solutions leader. Integration is progressing as planned, with GUIDE grant revenue incorporated into the fiscal outlook.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-09-08
Description

Tactile Medical acquired AffloVest from International Biophysics Corporation on September 8, 2021, to expand its treatment offerings for chronic respiratory conditions. The deal supports the company's growth and margin targets, including a 20%+ revenue increase and gross margins above 70%. The acquisition contributed significantly to Tactile Medical's revenue and profitability, with airway clearance revenue growing 66% YoY in Q4 2025.

Strategic tierCoreTypeTechnology or Integration
Description

Tactile Medical partnered with Parachute Health to offer digital pneumatic compression device ordering at no cost to clinicians. The platform provides a guided 5-step ordering process meeting insurance requirements, real-time communication with Tactile Medical, one-click digital signatures, and visibility into patient order status with real-time updates. Replaces/augments traditional fax-based ordering.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Tactile Medical is listed on the VA Federal Supply Schedule (36F79718D0519), allowing the company to provide pneumatic compression devices to Veterans for management of chronic swelling and venous insufficiency at home. Local representatives assist VA healthcare teams with patient selection, measuring, and in-home training. VA covers full device cost with no Veteran copay. NPI: 1427131424, DUNS: 146295980.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swedish-listed medical device company with a dedicated DVT/pneumatic compression portfolio (e.g., Flowtron) and the largest sequential compression system share in Europe (18–20%). Directly comparable product category, target patient populations (lymphedema, DVT prophylaxis, CVI), and reimbursement-driven DME business model.

TypeBroad incumbent
Description

U.S. healthcare distributor and medical products company with at-Home Solutions and DME businesses covering compression, ostomy, and urological products. Operates a broader portfolio across distribution, at-home medical, and acute care, with 12–14% share of the European sequential compression market as a competitor to Tactile Medical.

TypeDirect peer
Description

U.S. medical device manufacturer specializing in pneumatic compression pumps (e.g., Sequential Circulator, Lympha Press) for lymphedema, venous insufficiency, and wound care. Closely aligned product offering, clinical indications, and reimbursement-driven DME go-to-market.

TypeDirect peer
Description

Specialty DME manufacturer of intermittent pneumatic compression devices for DVT prophylaxis and lymphedema. Smaller scale than Tactile Medical but competes in the same HCPCS-coded product categories with a similar clinician-driven prescription model.

TypeBroad incumbent
Description

Medical technology company with a strong DME and orthopedic bracing portfolio (DJO, Aircast, DonJoy), addressing recovery, lymphedema, and rehabilitation through clinician channels. Broader portfolio than Tactile Medical but overlapping patient populations and durable medical equipment distribution model.

TypeBroad incumbent
Description

Baxter's Patient Support Systems business (acquired via Hillrom) includes the MetaTherapy/Volara and The Vest HFCWO airway clearance systems, directly comparable to AffloVest. Large incumbent with hospital and home-channel reach into respiratory and chronic care DME.

TypeDirect peer
Description

U.S. medical device company focused exclusively on high-frequency chest wall oscillation (HFCWO) airway clearance systems (SmartVest), directly competing with AffloVest in cystic fibrosis, bronchiectasis, and neuromuscular respiratory indications. Single-product company with similar reimbursement-driven DME model.

TypeRegional player
Description

Israel-based manufacturer of Lympha Press sequential and pneumatic compression systems distributed internationally. Directly comparable product technology and lymphedema/venous indications; primarily serves non-U.S. markets where Tactile Medical has limited share.

TypeBroad incumbent
Description

U.S. medical products distribution and Patient Direct (home healthcare) company, including Apria Healthcare following the 2022 acquisition. Broad DME distribution and at-home medical equipment platform overlapping Tactile Medical's direct-to-patient fulfillment model.

TypeBroad incumbent
Description

Diversified medical technology company with tissue regeneration, neurosurgery, and ENT businesses, including products serving chronic wound, lymphedema-adjacent, and home-care channels. Broader portfolio but comparable mid-cap public medtech scale and clinician-driven specialty distribution model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tactile Medical

At-home pneumatic compression therapy devicestactilemedical.com

Tactile Medical (NASDAQ: TCMD) develops and markets FDA-cleared at-home pneumatic compression devices (Flexitouch Plus, Nimbl, Entre Plus) and the AffloVest HFCWO airway clearance system, serving U.S. patients with lymphedema, lipedema, chronic venous insufficiency, and chronic respiratory conditions through prescription-based sales reimbursed by Medicare, the VA, and commercial health plans.

What Tactile Medical does

Tactile Medical (legal name Tactile Systems Technology, Inc.; NASDAQ: TCMD) is a Minneapolis-based medical technology company that develops, manufactures, and markets at-home pneumatic compression therapy systems and high-frequency chest wall oscillation (HFCWO) airway clearance devices. Its portfolio targets chronic conditions including lymphedema (primary, secondary, head and neck, and lipedema-related), chronic venous insufficiency (CVI), nonhealing venous leg ulcers, and chronic respiratory disorders such as cystic fibrosis, bronchiectasis, and neuromuscular disease. The company estimates the U.S. patient population at more than 20 million Americans affected by chronic swelling, including up to 40% of breast cancer survivors who develop lymphedema. Headcount is reported in the 251–500 range.

The core technology centers on proprietary multi-chambered intermittent pneumatic compression (IPC) garment systems — Flexitouch Plus (HCPCS E0652), Nimbl (HCPCS E0651), and the legacy Entre Plus — that deliver sequenced, wave-like pressure to mimic manual lymphatic drainage and stimulate lymphatic circulation. AffloVest, acquired from International Biophysics Corporation in September 2021, provides HFCWO airway clearance and received FDA 510(k) clearance for a next-generation connected version launching in June 2026. The ComfortEase garment line (zippers, numbered tabs, thinner fabric) was rolled out for lower extremity in June 2022 and upper extremity in June 2023. The Kylee mobile app (iOS/Android) pairs via Bluetooth with Flexitouch Plus and Nimbl to log treatments, track symptoms, and produce shareable clinician reports. The February 2026 acquisition of LymphaTech Inc. for $6.8M upfront adds 3D scanning technology for lymphedema assessment and monitoring. Clinical evidence cited includes 19+ clinical studies, 24+ peer-reviewed articles, and 1,800+ studied patients, with reported outcomes such as 88% (lower body) and 95% (upper body) limb volume reduction and 97% of head and neck patients reporting softer fibrotic tissue.

The business model is prescription-based, durable medical equipment (DME) reimbursed by Medicare, the Veterans Affairs Federal Supply Schedule (FSS 36F79718D0519), and commercial health plans covering more than 270 million lives. Tactile Medical monetizes primarily through one-time device sales (hardware), with accessory e-commerce (bags, batteries, garment pads) at shop.tactilemedical.com as a secondary, non-reimbursed stream; reimbursement and patient advocacy services are bundled into device revenue. Go-to-market combines enterprise-style direct field sales to clinicians (with digital ordering via Parachute Health), direct-to-patient fulfillment with in-home fitting and training, and a dedicated VA channel. FY2025 revenue of approximately $329.5M grew to Q1 2026 revenue of $75.3M (+23% YoY); FY2026 guidance was raised to $360–$368M with adjusted EBITDA of $49–$51M and gross margin reaching 76.5% in Q1 2026.

Tactile Medical firmographics

Firmographics
Name
Tactile Medical
Legal name
Tactile Systems Technology, Inc.
Website
https://tactilemedical.com
Company type
Public
Founded year
1995
Operating status
Operating
Headcount range
251–500 employees
Short description
Tactile Medical (NASDAQ: TCMD) develops and markets FDA-cleared at-home pneumatic compression devices (Flexitouch Plus, Nimbl, Entre Plus) and the AffloVest HFCWO airway clearance system, serving U.S. patients with lymphedema, lipedema, chronic venous insufficiency, and chronic respiratory conditions through prescription-based sales reimbursed by Medicare, the VA, and commercial health plans.
Ownership category
akta.pro rank

Tactile Medical industry classification

Industry
Product category
At-home pneumatic compression therapy devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
akta.pro secondary industries
Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments) (HLAHALAF), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM), Durable Medical Equipment (DME) Sales & Rentals (HSABAKAA)

Keywords

  • At-home pneumatic compression
  • Lymphedema therapy devices
  • Airway clearance vests
  • Chronic venous insufficiency treatment
  • Durable medical equipment

Where Tactile Medical is headquartered

Location

Headquarters

HQ city
Minneapolis
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Tactile Medical business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Others

Revenue model

  1. Pneumatic compression device sales: Primary revenue stream from sale of Flexitouch Plus, Nimbl, Entre Plus, and AffloVest systems reimbursed by Medicare, Veterans Affairs, and commercial health plans representing more than 270 million lives. Devices are prescription-based and typically one-time purchases per patient.
  2. Accessories sales via online storefront: Direct e-commerce sales of accessories including travel bags, rechargeable batteries, power cords, and replacement garment pads through shop.tactilemedical.com. Items are not eligible for insurance reimbursement and require credit card payment.
  3. Reimbursement and patient advocacy services: Value-add service bundled with device sales: experienced reimbursement specialists streamline insurance navigation, prior authorizations, and appeals for patients, included as part of the total cost of the prescribed device.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goInsurance-reimbursed DME (Flexitouch Plus, Nimbl, Entre Plus, AffloVest)
One time/ perpetual licensePay-as-you-goAccessories e-commerce (bags, batteries, garment pads)

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Tactile Medical product offering

Product offering

Core offering

Tactile Medical develops, manufactures, and distributes at-home pneumatic compression therapy devices (Flexitouch Plus, Nimbl, Entre Plus) for the treatment of lymphedema, lipedema, and chronic venous insufficiency, plus the AffloVest high-frequency chest wall oscillation airway clearance system for chronic respiratory conditions. Devices are prescription-based durable medical equipment reimbursed by Medicare, Veterans Affairs, and commercial health plans, and are complemented by the Kylee Bluetooth-connected patient mobile app and accessories sold direct via the company's e-commerce storefront.

Product overview

Tactile Medical is a single-vendor medical technology company that develops and markets an integrated portfolio of at-home pneumatic compression therapy products for chronic disorders, principally lymphedema, lipedema, chronic venous insufficiency (CVI), and chronic respiratory conditions. The portfolio is built around the core Flexitouch Plus advanced pneumatic compression system (HCPCS E0652) and the Nimbl basic pneumatic compression system (HCPCS E0651), supported by the legacy Entre Plus system, the AffloVest high-frequency chest wall oscillation airway clearance system, the redesigned ComfortEase garment line for Flexitouch Plus, and the Kylee Bluetooth-connected companion mobile app for symptom tracking and treatment sharing. The acquisition of LymphaTech adds 3D scanning technology for lymphedema assessment and monitoring, extending the offering from discrete products toward an integrated digital lymphedema solutions platform with connected care and remote monitoring capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • Flexitouch: Advanced intermittent pneumatic compression device system (including Flexitouch Plus) clinically proven for at-home self-management of lymphedema and nonhealing venous leg ulcers. Includes head/neck, upper body, and lower body garment variants with the ComfortEase garment line.
  • Nimbl
  • Kylee
  • AffloVest
  • Entre Plus
  • ComfortEase

Products and services

  • Flexitouch Plus System Advanced intermittent pneumatic compression device (HCPCS E0652) that stimulates the lymphatic system for at-home self-management of lymphedema, chronic venous insufficiency (CVI), and nonhealing venous leg ulcers. Available with region-specific ComfortEase garments for head and neck, upper body, and lower body treatment.
  • Nimbl System Compact, Bluetooth-connected pneumatic compression device (HCPCS E0651) with a small, light controller and eight sequential compression chambers for upper and lower body treatment of lymphedema and CVI. Pairs with the Kylee app for treatment tracking.
  • AffloVest High-frequency chest wall oscillation (HFCWO) airway clearance vest system for patients with chronic respiratory conditions including cystic fibrosis, bronchiectasis, COPD, and neuromuscular disorders. Gently loosens and mobilizes mucus for easier clearance at home or on the go.
  • Entre Plus System Intermittent pneumatic compression device (HCPCS E0651) for upper and lower body treatment of lymphedema. Supports approximately 60-minute treatment sessions in single-garment and bilateral configurations. Predecessor to the Nimbl product line.
  • Kylee App Free mobile app (iOS 18+ and Android 14+) for lymphedema and chronic swelling self-management. Connects via Bluetooth to Flexitouch Plus and Nimbl devices to track daily symptoms (swelling, pain, heaviness), log treatments, set reminders, monitor order status, and generate shareable activity reports of up to six months of history for healthcare teams.
  • Tactile Medical Accessories Direct-to-consumer e-commerce accessories (travel bags, rechargeable batteries, power cords, replacement garment pads) sold via shop.tactilemedical.com with FedEx Ground shipping, 60-day return window on unopened items, and credit card payment.

Quantifiable outcome

  • 88% of patients experience limb volume reduction with Flexitouch Plus lower body treatment
  • +5 more outcomes

Companies that use Tactile Medical

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Tactile Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Tactile Medical partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • LymphaTech Inc.coreStrategic or Co-development Partner · 18 February 2026Tactile Medical acquired LymphaTech Inc. for $6.8 million in upfront cash (with potential milestone-based payments) to enhance its portfolio in lymphedema solutions and digital care. LymphaTech is a privately held medical technology company pioneering 3D scanning technology for assessing and monitoring lymphedema patients, supporting Tactile Medical's evolution from a product-based company to an integrated lymphedema solutions leader. Integration is progressing as planned, with GUIDE grant revenue incorporated into the fiscal outlook.
  • International Biophysics CorporationcoreOEM/ Whitelabel/ Licensing Partner · 8 September 2021Tactile Medical acquired AffloVest from International Biophysics Corporation on September 8, 2021, to expand its treatment offerings for chronic respiratory conditions. The deal supports the company's growth and margin targets, including a 20%+ revenue increase and gross margins above 70%. The acquisition contributed significantly to Tactile Medical's revenue and profitability, with airway clearance revenue growing 66% YoY in Q4 2025.
  • Parachute HealthcoreTechnology or IntegrationTactile Medical partnered with Parachute Health to offer digital pneumatic compression device ordering at no cost to clinicians. The platform provides a guided 5-step ordering process meeting insurance requirements, real-time communication with Tactile Medical, one-click digital signatures, and visibility into patient order status with real-time updates. Replaces/augments traditional fax-based ordering.
  • U.S. Department of Veterans Affairs (VA)coreChannel Partner/ Reseller/ DistributorTactile Medical is listed on the VA Federal Supply Schedule (36F79718D0519), allowing the company to provide pneumatic compression devices to Veterans for management of chronic swelling and venous insufficiency at home. Local representatives assist VA healthcare teams with patient selection, measuring, and in-home training. VA covers full device cost with no Veteran copay. NPI: 1427131424, DUNS: 146295980.

Scale indicators11 records

Recent moves6 records

Expansion highlights7 records

Tactile Medical competitors and assessment

Company assessment

Direct peers

  • Arjo AB: Swedish-listed medical device company with a dedicated DVT/pneumatic compression portfolio (e.g., Flowtron) and the largest sequential compression system share in Europe (18–20%). Directly comparable product category, target patient populations (lymphedema, DVT prophylaxis, CVI), and reimbursement-driven DME business model.
  • BioCompression Systems: U.S. medical device manufacturer specializing in pneumatic compression pumps (e.g., Sequential Circulator, Lympha Press) for lymphedema, venous insufficiency, and wound care. Closely aligned product offering, clinical indications, and reimbursement-driven DME go-to-market.
  • Devon Medical Products: Specialty DME manufacturer of intermittent pneumatic compression devices for DVT prophylaxis and lymphedema. Smaller scale than Tactile Medical but competes in the same HCPCS-coded product categories with a similar clinician-driven prescription model.
  • Electromed: U.S. medical device company focused exclusively on high-frequency chest wall oscillation (HFCWO) airway clearance systems (SmartVest), directly competing with AffloVest in cystic fibrosis, bronchiectasis, and neuromuscular respiratory indications. Single-product company with similar reimbursement-driven DME model.

Broad incumbents

  • Cardinal Health: U.S. healthcare distributor and medical products company with at-Home Solutions and DME businesses covering compression, ostomy, and urological products. Operates a broader portfolio across distribution, at-home medical, and acute care, with 12–14% share of the European sequential compression market as a competitor to Tactile Medical.
  • Enovis Corporation (DJO): Medical technology company with a strong DME and orthopedic bracing portfolio (DJO, Aircast, DonJoy), addressing recovery, lymphedema, and rehabilitation through clinician channels. Broader portfolio than Tactile Medical but overlapping patient populations and durable medical equipment distribution model.
  • Hillrom (Baxter International): Baxter's Patient Support Systems business (acquired via Hillrom) includes the MetaTherapy/Volara and The Vest HFCWO airway clearance systems, directly comparable to AffloVest. Large incumbent with hospital and home-channel reach into respiratory and chronic care DME.
  • Owens & Minor: U.S. medical products distribution and Patient Direct (home healthcare) company, including Apria Healthcare following the 2022 acquisition. Broad DME distribution and at-home medical equipment platform overlapping Tactile Medical's direct-to-patient fulfillment model.
  • Integra LifeSciences: Diversified medical technology company with tissue regeneration, neurosurgery, and ENT businesses, including products serving chronic wound, lymphedema-adjacent, and home-care channels. Broader portfolio but comparable mid-cap public medtech scale and clinician-driven specialty distribution model.

Regional players

  • Mego Afek Ltd. Israel-based manufacturer of Lympha Press sequential and pneumatic compression systems distributed internationally. Directly comparable product technology and lymphedema/venous indications; primarily serves non-U.S. markets where Tactile Medical has limited share.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Tactile Medical social profiles

Digital presence

Tactile Medical compliance and trust

Trust signal

Compliance2 records

Tactile Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tactile Medical leadership team

Management profile

Number of profiles

Profiles3 records

Tactile Medical subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Tactile Medical funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tactile Medical M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tactile Medical

What does Tactile Medical do?

Tactile Medical develops, manufactures, and distributes at-home pneumatic compression therapy devices (Flexitouch Plus, Nimbl, Entre Plus) for the treatment of lymphedema, lipedema, and chronic venous insufficiency, plus the AffloVest high-frequency chest wall oscillation airway clearance system for chronic respiratory conditions. Devices are prescription-based durable medical equipment reimbursed by Medicare, Veterans Affairs, and commercial health plans, and are complemented by the Kylee Bluetooth-connected patient mobile app and accessories sold direct via the company's e-commerce storefront.

Is Tactile Medical a public or private company?

Tactile Medical is a public company. It is classified as public and is currently operating.

When was Tactile Medical founded?

Tactile Medical was founded in 1995. It employs 251 to 500 people.

Where is Tactile Medical based?

Tactile Medical is headquartered in Minneapolis, United States, in the North America region.

How does Tactile Medical make money?

Three revenue lines are on record. Pneumatic compression device sales are the primary driver. The others are accessories sales via online storefront and reimbursement and patient advocacy services.

Who are Tactile Medical's main competitors?

Direct peers on record are Arjo AB, BioCompression Systems, Devon Medical Products and Electromed. Broad incumbents are Cardinal Health, Enovis Corporation (DJO), Hillrom (Baxter International), Owens & Minor and Integra LifeSciences. Mego Afek Ltd. is listed as a regional player.

Does Tactile Medical have an API?

No public API is recorded for Tactile Medical.

What industry is Tactile Medical in?

Tactile Medical's product category is At-home pneumatic compression therapy devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLAHALAF, Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsBank of America Corp DE Makes New $1.56 Million Investment in Tactile Systems Technology, Inc. $TCMDBank of America Corp DE acquired a new stake in Tactile Systems Technology, buying 52,370 shares valued at about $1.56 million in Q2. CEO Sheri Dodd sold 10,978 shares on August 10th for $323,192.32, reducing her stake by 4.5%. Analysts rate the stock a Moderate Buy with a $38.40 target.American Banking and Market NewsTactile Systems Technology, Inc. (NASDAQ:TCMD) Given Consensus Rating of “Moderate Buy” by BrokeragesTactile Systems Technology shares received a consensus "Moderate Buy" rating from six brokerages, with an average 12-month target of $38.40. The company reported Q2 EPS of $0.34, beating estimates, and revenue of $85.70 million. CEO Sheri Dodd sold 10,978 shares at $29.44, and institutional ownership stands at 83.43%.AInvestAn Insider 'Proposes to Sell' More Tactile Systems Than ExistsA data error in a news feed incorrectly reported that Tactile Systems Technology insider William Burke proposed to sell $540 million in shares, a figure exceeding the company's total market capitalization. The actual filing revealed a modest sale of 11,255 restricted shares worth approximately $260,000, while CEO Sheri Dodd separately sold 11% of her stake for $323,000 following the company's second-quarter earnings report.Ticker ReportTactile Systems Technology (NASDAQ:TCMD) Cut to Buy at Wall Street ZenWall Street Zen downgraded Tactile Systems Technology from a strong-buy to a buy rating, while other analysts such as B. Riley Financial raised their ratings and price targets for the company. Tactile Systems Technology recently reported quarterly earnings of $0.34 per share, beating consensus estimates, with revenue also exceeding expectations. Institutional investors including BlackRock Inc. increased their stakes in the medical device manufacturer during recent quarters.The Motley FoolTactile Systems Technology (TCMD) Q2 2026 Earnings Call TranscriptTactile Systems Technology reported a 9% year-over-year increase in Q2 revenue to $85.7 million, driven by strong performance in its lymphedema product line and improved profitability metrics including a 49% rise in adjusted EBITDA. The company updated its full-year revenue guidance to $360–$366 million due to temporary inventory adjustments in the airway clearance segment while securing an exclusive U.S. distribution agreement for MyoSleeve through the Department of Defense. Additionally, Tactile submitted an application for an expanded FDA indication for LymphaTech as a diagnostic aid, with approval targeted for 2027.Markets DailyTactile Systems Technology (NASDAQ:TCMD) & Check-Cap (NASDAQ:MBAI) Head-To-Head SurveyTactile Systems Technology and Check-Cap are being compared based on various financial metrics and analyst recommendations. Tactile Systems Technology demonstrates stronger financial performance with higher revenue, net income, and institutional ownership compared to Check-Cap. Analysts favor Tactile Systems Technology, indicating a more favorable investment opportunity than Check-Cap.American Banking and Market NewsBTIG Research Lowers Tactile Systems Technology (NASDAQ:TCMD) Price Target to $39.00BTIG Research lowered its price target for Tactile Systems Technology from $40.00 to $39.00 while maintaining a "buy" rating. The company recently reported second-quarter earnings of $0.34 per share, significantly beating analyst estimates of $0.14. Other analysts also adjusted their ratings, with B. Riley upgrading the stock and Weiss Ratings maintaining a hold.Markets DailyTactile Systems Technology Q2 Earnings Call HighlightsTactile Systems Technology reported a 9% year-over-year revenue increase to $85.7 million for the second quarter, driven by 12% growth in its lymphedema business and improved profitability metrics including a 142% rise in net income. The company updated its full-year outlook to reflect temporary inventory adjustments in its airway-clearance segment while maintaining guidance for low-double-digit lymphedema growth and approximately $50 million in adjusted EBITDA. Additionally, Tactile expanded its portfolio through an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve device and announced progress on FDA indications for its LymphaTech system.Simply Wall StTactile Systems Technology (TCMD) Stock Price Drop Defies Profit MomentumTactile Systems Technology experienced a 17% drop in stock price despite reporting a profitable quarter, with Q2 net income of US$7.8 million on revenues of US$85.7 million. The company's performance continues to improve, including a gross margin increase to 76.3% and significant year-over-year revenue growth in its lymphedema segment. However, concerns about execution risks and potential impacts on margins have led investors to react negatively to the price movement.MarketScreenerTactile Systems Technology Shares Fall After Q2 Results, Lowered 2026 Revenue GuidanceTactile Systems Technology, Inc. reported Q2 results and lowered its revenue guidance for 2026, which caused its shares to fall. The company's revenue projections and stock performance are influenced by its financial outlook.